NOVEL HYDANTOIN DERIVATIVES AS METALLOPROTEINASE INHIBITORS Russian patent published in 2010 - IPC C07D401/12 C07D401/14 A61K31/4375 A61K31/4725 A61K31/506 A61P11/06 

Abstract RU 2378269 C2

FIELD: chemistry.

SUBSTANCE: present invention relates to novel hydantoin derivatives of formula or pharmaceutically acceptable salt thereof, where R1 is H, halogen, CF3 or CH2CN; R2 is C1-3alkyl; each of A, A1 and B independently represents CH or N. The invention also relates to a method for synthesis of a formula I compound, to a pharmaceutical composition based a formula I compound and use thereof in making a medicinal agent.

EFFECT: obtaining novel hydantoin derivatives with inhibitory activity towards metalloproteinase.

10 cl, 1 tbl, 6 ex

Similar patents RU2378269C2

Title Year Author Number
NEW DERIVATIVES OF HYDANTOIN AS INHIBITORS OF METAL PROTEINASES 2005
  • Gabos Balint
  • Lundkvist Mikaehl'
  • Munk Af Rozenshel'D Magnus
  • Shamovski Igor'
  • Zlatojdski Pavol
RU2376301C2
NEW HYDANTOIC DERIVATIVES FOR TREATING OBSTRUCTIVE AIRWAY DISEASES 2005
  • Gabos Balint
  • Ripa Lena
  • Stenvall' Kristina
RU2386629C2
HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS 2018
  • Vadivelu, Saravanan
  • Rajagopal, Sridharan
  • Burri, Raghunadha Reddy
  • Garapaty, Shivani
  • Sivanandhan, Dhanalakshmi
  • Thakur, Manish Kumar
  • Natarajan, Tamizharasan
  • Swamy, Indu N
  • Nagaraju, Nagendra
  • Kanagaraj, Subramaniam
  • Mohd, Zainuddin
  • Sarkar, Sayantani
  • Samanta, Swapan Kumar
  • Hariprakash
RU2797822C2
HYDANTOIN DERIVATIVES USED AS MMP INHIBITORS 2007
  • Chapman Dehvid
  • Gabos Balint
  • Munk Av Rozenshold Magnus
RU2463301C2
INHIBITORS OF METALLOPROTEINASES, THEIR USING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 2002
  • Ehriksson Anders
  • Lepiste Matti
  • Lundkvist Mikaehl'
  • Munk Af Rozenskel'D Magnus
  • Zlatojdskij Pavol
RU2288228C2
HETEROCYCLIC COMPOUNDS AND METHODS OF APPLICATION 2009
  • Baehll Dzhonatan Bajldon
  • Buj Chinkh Tkhien
  • Kolmen Piter
  • Chabotar Piter
  • Dadli Danett A.
  • Fehjrbrazer Uehjn Dzh.
  • Flajgehr Dzhon A.
  • Lessin Gijom Loran
  • Ndubaku Chudi
  • Nikolakopulos Dzhordzh
  • Slibs Brehd Ehdmund
  • Smit Brajan Dzhon
  • Uotson Kejt Dzheffri
  • Ehlmor Stiven V.
  • Khasvol'D Liza A.
  • Petros Ehndrju M.
  • Sauehrs Ehndrju Dzh.
  • Tao Chzhi-Fu
  • Van Leh
  • Van Silu
  • Dezej Kurt
RU2525116C2
SUBSTITUTED CARBONUCLEOSIDES DERIVATIVES USED AS ANTICANCER AGENTS 2017
  • Kumpf, Robert Arnold
  • Mcalpine, Indrawan James
  • Mctigue, Michele Ann
  • Patman, Ryan
  • Rui, Eugene Yuanjin
  • Tatlock, John Howard
  • Tran-Dube, Michelle Bich
  • Wythes, Martin James
RU2712944C1
SUBSTITUTED 1,2-DIHYDRO[2,7]NAPHTHIRIDINES, PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARING AND APPLYING 2003
  • Ivashchenko A.V.
  • Vvedenskij V.Ju.
  • Ivanov Ju.V.
  • Khvat Aleksandr Viktorovich
  • Tkachenko S.E.
  • Okun' Il'Ja Matusovich
RU2243218C1
COMPOUNDS AND METHODS FOR USING 2009
  • Baehll Dzhonatan Bajldon
  • Buj Chinkh Tkhien
  • Kolmen Piter
  • Dadli Danett A.
  • Fehjrbrazer Uehjn Dzh.
  • Flajgehr Dzhon A.
  • Lessin Gijom Loran
  • Ndubaku Chudi
  • Nikolakopulos Dzhordzh
  • Raj Karl Stiven
  • Slibs Brehd Ehdmund
  • Smit Brajan Dzhon
  • Uotson Kejt Dzheffri
  • Ehlmor Stiven V.
  • Petros Ehndrju M.
  • Sauehrs Ehndrju Dzh.
  • Kzabotar Piter
RU2561109C2
BICYCLIC CONDENSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS 2016
  • Lee Katherine Lin
  • Allais Christophe Philippe
  • Dehnhardt Christoph Martin
  • Gavrin Lori Krim
  • Han Seungil
  • Hepworth David
  • Lee Arthur
  • Lovering Frank Eldridge
  • Mathias John Paul
  • Owen Dafydd Rhys
  • Papaioannou Nikolaos
  • Saiah Eddine
  • Strohbach Joseph Walter
  • Trzupek John David
  • Wright Stephen Wayne
  • Zapf Christoph Wolfgang
RU2684324C1

RU 2 378 269 C2

Authors

Gabos Balint

Lundkvist Mikaehl'

Munk Af Rozenshel'D Magnus

Shamovski Igor'

Zlatojdski Pavol

Dates

2010-01-10Published

2005-12-14Filed